Shareholders Equity: The sum of preferred and common equity items.
Dogwood Therapeutics, Inc (DWTX) had Shareholders Equity of $77.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-15.74M |
|
-- |
|
-- |
|
$15.81M |
|
$-15.81M |
|
$0.06M |
|
$-15.75M |
|
$-15.75M |
|
$-15.75M |
|
$-15.75M |
|
$-15.74M |
|
$-15.75M |
|
$-15.81M |
|
$-15.84M |
|
1.92M |
|
1.92M |
|
$-8.20 |
|
$-8.20 |
|
| Balance Sheet Financials | |
$11.66M |
|
$0.02M |
|
$80.34M |
|
$91.99M |
|
$2.60M |
|
-- |
|
$12.01M |
|
$14.61M |
|
$-33.07M |
|
$-2.74M |
|
|
Shareholders Equity |
$77.39M |
1.34M |
|
| Cash Flow Statement Financials | |
$-11.98M |
|
-- |
|
$7.25M |
|
$14.85M |
|
$10.13M |
|
$-4.73M |
|
$0.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
47.62% |
|
573.87% |
|
-17.12% |
|
-20.35% |
|
$57.75 |
|
$-6.24 |
|
$-6.24 |
|